Article
Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases.
International journal of molecular sciences - 28 Dec 2021
Cannon Alkeiver S, Nagarkatti Prakash S, Nagarkatti Mitzi
Abstract excerpt
For decades, activation of Aryl Hydrocarbon Receptor (AhR) was excluded from consideration as a therapeutic approach due to the potential toxic effects of AhR ligands and the induction of the cytochrome P450 enzyme, Cyp1a1, following AhR activation. However, it is now understood that AhR activation not only serves as an environmental sensor that regulates the effects of environmental toxins, but also as a key...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
